Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders??? Equity

v3.25.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Common Stock
Additional Paid-in Capital
Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 130 $ 61,855,659 $ (661) $ (19,356,880) $ 42,498,248
Balance (in Shares) at Dec. 31, 2022 1,301,921        
Stock-based compensation:          
-restricted stock units $ 1 71,735 71,736
-restricted stock units (in Shares) 5,832        
-stock options 520,533 520,533
Common stock repurchased in tender offer $ (27) (3,726,389) (3,726,416)
Common stock repurchased in tender offer (in Shares) (266,171)        
Foreign currency translation (3,991) (3,991)
Net loss (15,961,658) (15,961,658)
Balance at Dec. 31, 2023 $ 104 58,721,538 (4,652) (35,318,538) 23,398,452
Balance (in Shares) at Dec. 31, 2023 1,041,582        
Stock-based compensation:          
-warrants 7,866 7,866
Issuance of September 2024 pre-funded and common warrants, net 4,517,285 4,517,285
Issuance of common stock from the exercise of pre-funded warrants, net $ 35 314 $ 349
Issuance of common stock from the exercise of pre-funded warrants, net (in Shares) 348,513       348,513
Deemed dividend - warrant modification 359,656 (359,656)
-restricted stock units 117,460 117,460
-restricted stock units (in Shares) 4,168        
-stock options 648,367 648,367
Foreign currency translation (2,519) (2,519)
Net loss (13,904,584) (13,904,584)
Balance at Dec. 31, 2024 $ 139 $ 64,372,486 $ (7,171) $ (49,582,778) $ 14,782,676
Balance (in Shares) at Dec. 31, 2024 1,394,263